Prenatal Screening Tests: Ultrasound, Blood Tests, and Genetic Risk

Prenatal screening tests help estimate the chance of certain chromosome conditions, birth differences, and pregnancy concerns before birth. These tests are optional, generally safe, and best understood with guidance from a qualified obstetrician or genetic counselor.

Overview

Prenatal screening tests are medical tests offered during pregnancy to assess the chance of certain health conditions in the developing baby or pregnancy. They may include ultrasound examinations, blood tests, and genetic screening methods. The main goal is to provide information early enough for parents and healthcare teams to plan appropriate follow-up, additional testing, or specialized care if needed.

Screening tests are different from diagnostic tests. A screening test estimates risk, such as low risk or increased risk, but it usually cannot say with certainty whether a baby has a specific condition. A diagnostic test, such as chorionic villus sampling or amniocentesis, examines fetal or placental cells and can provide a more definitive answer for many chromosome conditions.

For many expectant parents, prenatal screening offers reassurance. For others, it identifies a need for closer monitoring or further evaluation. The choice to have screening is personal and should be supported by clear information, respectful counseling, and time to ask questions.

What Prenatal Screening Can and Cannot Tell

Prenatal screening can estimate the likelihood of chromosome conditions such as Down syndrome, Edwards syndrome, or Patau syndrome. Some tests may also screen for differences involving sex chromosomes. Ultrasound can assess fetal growth, heartbeat, anatomy, placental position, amniotic fluid, and markers that may be associated with genetic or structural conditions.

Screening cannot detect every condition. A low-risk result greatly reduces the chance of the conditions tested, but it does not guarantee that the baby has no health issue. Likewise, a higher-risk result is not a diagnosis. Many pregnancies with increased-risk screening results are later found to be unaffected after further assessment.

Common prenatal screening may include:

• First-trimester ultrasound, including nuchal translucency measurement when appropriate
• Maternal blood tests measuring pregnancy-related proteins and hormones
• Second-trimester blood screening, sometimes called the triple or quadruple test
• Non-invasive prenatal testing, also known as cell-free DNA screening
• Detailed anatomy ultrasound, usually performed in the second trimester

Ultrasound Screening During Pregnancy

Ultrasound uses sound waves to create images of the developing baby and pregnancy structures. It does not use radiation. In early pregnancy, ultrasound can help confirm the pregnancy location, estimate gestational age, check the fetal heartbeat, and identify multiple pregnancies such as twins.

A first-trimester ultrasound may include nuchal translucency screening, usually performed in a specific early pregnancy window. This measures a small fluid-filled space at the back of the baby’s neck. When combined with maternal age and blood test results, it helps estimate the chance of certain chromosome conditions.

The second-trimester anatomy scan is a key part of prenatal care. It carefully evaluates major fetal structures, including the brain, spine, heart, kidneys, limbs, face, and abdominal organs. Some structural differences can be identified at this stage, although not all conditions are visible on ultrasound and some may develop or become clearer later in pregnancy.

Prenatal Blood Tests and Non-Invasive Prenatal Testing

Several blood tests may be offered during pregnancy. Some are routine maternal health tests, such as blood type, anemia screening, immunity checks, and infection screening. Others are specifically designed to estimate fetal genetic risk by measuring pregnancy-related substances in the mother’s blood.

First-trimester combined screening typically uses ultrasound findings, maternal age, and blood markers to estimate risk. Second-trimester screening may be offered when first-trimester screening was not done or as part of an integrated approach. These tests may also help assess the risk of open neural tube defects through markers such as alpha-fetoprotein, interpreted alongside ultrasound findings.

Non-invasive prenatal testing, or NIPT, analyzes small fragments of placental DNA circulating in the pregnant person’s blood. It can be performed from early pregnancy after a minimum gestational age determined by the healthcare provider. NIPT is highly accurate for common trisomies, especially Down syndrome, but it remains a screening test and positive or high-risk results should be confirmed with diagnostic testing before major medical decisions are made.

Understanding Genetic Risk Results

Results from prenatal screening are usually reported as low risk, increased risk, or sometimes as a numerical chance. For example, a result may indicate that the chance of a certain chromosome condition is higher or lower than a defined screening threshold. This does not describe the severity of a condition, and it does not predict every aspect of a child’s future health.

Several factors can influence results, including gestational age, maternal age, weight, twin pregnancy, laboratory method, and ultrasound measurements. In some cases, a test may return no result or an inconclusive result. This does not automatically mean there is a problem, but the healthcare team may recommend repeating the test, having a detailed ultrasound, or considering diagnostic testing.

Genetic counseling can be very helpful when results are complex or unexpected. A genetic counselor or maternal-fetal medicine specialist can explain what was tested, what the result means, what remains unknown, and what options are available. Counseling should be non-directive, meaning it supports informed decision-making without pressuring parents toward one choice.

Diagnostic Testing After a Higher-Risk Screen

When a screening test suggests increased risk, diagnostic testing may be offered to confirm or rule out a specific chromosome condition. The main diagnostic tests used in pregnancy are chorionic villus sampling and amniocentesis. These procedures collect cells from the placenta or amniotic fluid for laboratory analysis.

Chorionic villus sampling is generally performed earlier in pregnancy than amniocentesis, while amniocentesis is usually performed later. The exact timing depends on gestational age, medical history, the reason for testing, and local clinical protocols. Both procedures are performed by trained specialists using ultrasound guidance.

Diagnostic procedures carry a small risk of complications, which should be discussed before testing. The decision to proceed depends on how much certainty parents want, the screening result, ultrasound findings, and personal values. Some families choose diagnostic testing for clarity, while others prefer ultrasound follow-up and preparation without invasive testing.

Preparing for Screening and Making Informed Choices

Before prenatal screening, patients may find it helpful to ask what the test looks for, how accurate it is, when results will be available, and what the next step would be if the result is higher risk. Understanding the purpose of the test can reduce confusion and help parents decide whether the information would be useful to them.

It is also helpful to review personal and family medical history. A previous pregnancy affected by a genetic condition, known carrier status, certain ultrasound findings, or a family history of inherited disease may change the recommended testing approach. In these situations, targeted genetic counseling or carrier screening may be discussed.

Screening decisions are not only medical; they can also be emotional, ethical, cultural, or religious. Parents may choose full screening, limited screening, or no genetic screening. A respectful healthcare team should provide balanced information and support the family’s informed preferences while continuing routine pregnancy care.

When to See a Doctor

Pregnant patients should attend regular prenatal visits and discuss screening options early, ideally during the first trimester. Timely discussion matters because some tests are performed only during specific pregnancy windows. Patients should also contact their healthcare provider if they are unsure about test results, receive an increased-risk result, or are asked to consider additional testing.

Specialist input may be recommended when ultrasound shows an unexpected finding, screening results are inconclusive, there is a family history of a genetic condition, or the pregnancy is higher risk for another reason. Maternal-fetal medicine specialists, obstetricians, radiologists, laboratory physicians, pediatric specialists, and genetic counselors may work together to guide care.

Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and manage prenatal screening findings for international patients, including coordinated imaging, laboratory testing, and specialist consultation when appropriate. Any patient considering prenatal screening should speak with a qualified doctor who can interpret results in the context of the individual pregnancy.

Frequently asked questions

Are prenatal screening tests required during pregnancy?

No. Prenatal screening tests are optional. Healthcare providers offer them so parents can learn more about the pregnancy and potential genetic or structural risks, but the decision should be based on informed consent and personal values.

What is the difference between screening and diagnostic testing?

Screening estimates the chance of a condition and usually reports results as low risk or increased risk. Diagnostic testing examines fetal or placental cells and can confirm or rule out many chromosome conditions with much greater certainty. A higher-risk screening result is usually followed by counseling and the option of diagnostic testing.

Is non-invasive prenatal testing the same as amniocentesis?

No. Non-invasive prenatal testing is a blood test from the pregnant person and is considered a screening test. Amniocentesis is an invasive diagnostic procedure that samples amniotic fluid and can provide a more definitive chromosome result.

Can a normal ultrasound guarantee that the baby is healthy?

A normal ultrasound is reassuring, but it cannot guarantee that every condition is absent. Some genetic, metabolic, developmental, or subtle structural conditions may not be visible before birth. Ultrasound is one important part of prenatal assessment, not a complete guarantee.

What happens if a screening result is high risk?

A high-risk result does not mean the baby definitely has the condition. The healthcare provider may recommend genetic counseling, a detailed ultrasound, repeat or additional screening, or diagnostic testing such as chorionic villus sampling or amniocentesis. The next step depends on the specific result and the parents' preferences.

When should prenatal screening be discussed?

Screening options should be discussed early in pregnancy because some tests are available only during certain weeks. The first prenatal visits are a good time to review medical history, family history, and preferences. Patients who start care later in pregnancy can still discuss available screening and ultrasound options.

References

• American College of Obstetricians and Gynecologists
• Society for Maternal-Fetal Medicine
• World Health Organization
• National Health Service
• International Society of Ultrasound in Obstetrics and Gynecology

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.